Katlama C - Search Results

1

Treatment interruption in chronically HIV-infected patients with an ultralow HIV reservoir.

Calin R, Hamimi C, Lambert-Niclot S, Carcelain G, Bellet J, Assoumou L, Tubiana R, Calvez V, Dudoit Y, Costagliola D, Autran B, Katlama C; ULTRASTOP Study Group. Calin R, et al. Among authors: katlama c. AIDS. 2016 Mar 13;30(5):761-9. doi: 10.1097/QAD.0000000000000987. AIDS. 2016. PMID: 26730568

2

CD4+CD7-CD57+ T cells: a new T-lymphocyte subset expanded during human immunodeficiency virus infection.

Legac E, Autran B, Merle-Beral H, Katlama C, Debre P. Legac E, et al. Among authors: katlama c. Blood. 1992 Apr 1;79(7):1746-53. Blood. 1992. PMID: 1373086 Free article.

3

Virological markers in the cerebrospinal fluid from HIV-1-infected individuals.

Buffet R, Agut H, Chieze F, Katlama C, Bolgert F, Devillechabrolle A, Diquet B, Schuller E, Pierrot-Deseilligny C, Gentilini M, et al. Buffet R, et al. Among authors: katlama c. AIDS. 1991 Dec;5(12):1419-24. doi: 10.1097/00002030-199112000-00002. AIDS. 1991. PMID: 1814327

4

T cell receptor gamma/delta+ lymphocyte subsets during HIV infection.

Autran B, Triebel F, Katlama C, Rozenbaum W, Hercend T, Debre P. Autran B, et al. Among authors: katlama c. Clin Exp Immunol. 1989 Feb;75(2):206-10. Clin Exp Immunol. 1989. PMID: 2522839 Free PMC article.

5

Atovaquone as long-term suppressive therapy for toxoplasmic encephalitis in patients with AIDS and multiple drug intolerance. Atovaquone Expanded Access Group.

Katlama C, Mouthon B, Gourdon D, Lapierre D, Rousseau F. Katlama C, et al. AIDS. 1996 Sep;10(10):1107-12. AIDS. 1996. PMID: 8874627 Clinical Trial.

6

Dynamics of viral variants in HIV-1 Nef and specific cytotoxic T lymphocytes in vivo.

Haas G, Plikat U, Debré P, Lucchiari M, Katlama C, Dudoit Y, Bonduelle O, Bauer M, Ihlenfeldt HG, Jung G, Maier B, Meyerhans A, Autran B. Haas G, et al. Among authors: katlama c. J Immunol. 1996 Nov 1;157(9):4212-21. J Immunol. 1996. PMID: 8892659

7

Effects of lamivudine on replication of hepatitis B virus in HIV-infected men.

Benhamou Y, Katlama C, Lunel F, Coutellier A, Dohin E, Hamm N, Tubiana R, Herson S, Poynard T, Opolon P. Benhamou Y, et al. Among authors: katlama c. Ann Intern Med. 1996 Nov 1;125(9):705-12. doi: 10.7326/0003-4819-125-9-199611010-00001. Ann Intern Med. 1996. PMID: 8929003

8

Consequences for the management of cytomegalovirus.

Katlama C. Katlama C. AIDS. 1996 Nov;10 Suppl 1:S43-6. AIDS. 1996. PMID: 8970676 Review.

9

Additional mutations detected in sequential HIV-1 isolates from ZDV-treated patients.

Magierowska-Jung M, Agut H, Katlama C, Autran B, Huraux JM. Magierowska-Jung M, et al. Among authors: katlama c. J Med Virol. 1997 Jan;51(1):48-55. J Med Virol. 1997. PMID: 8986949

10

Vaccine therapy in early HIV-1 infection using a recombinant canarypox virus expressing gp160MN (ALVAC-HIV): a double-blind controlled randomized study of safety and immunogenicity.

Tubiana R, Gomard E, Fleury H, Gougeon ML, Mouthon B, Picolet H, Katlama C. Tubiana R, et al. Among authors: katlama c. AIDS. 1997 May;11(6):819-20. AIDS. 1997. PMID: 9143616 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

946 results

Search Page

Filters